SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-079900
Filing Date
2023-03-27
Accepted
2023-03-27 09:02:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d467150ddefa14a.htm DEFA14A 21035
  Complete submission text file 0001193125-23-079900.txt   22182
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 23761591
SIC: 3841 Surgical & Medical Instruments & Apparatus